Siddhartha Laskar Selected Research

Siddhartha Laskar Research Topics

Disease

24	Neoplasms (Cancer) 02/2024 - 01/2005
7	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2005
5	Hodgkin Disease (Hodgkin's Disease) 02/2024 - 09/2003
4	Lymphoma (Lymphomas) 01/2023 - 06/2006
4	Rhabdomyosarcoma 01/2023 - 10/2017
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 11/2020
3	Carcinoma (Carcinomatosis) 03/2009 - 10/2005
2	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 01/2018
2	Giant Cell Tumors (Giant Cell Tumor) 10/2021 - 10/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 08/2007
2	Neoplasm Metastasis (Metastasis) 03/2009 - 01/2005
2	Nasopharyngeal Carcinoma 11/2008 - 01/2004
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023
1	Cardiotoxicity 10/2022
1	Frailty 10/2022
1	Infections 05/2022
1	COVID-19 05/2022
1	Teratoma (Teratoid Tumor) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Chondrosarcoma 11/2021
1	Chordoma 11/2021
1	Pain (Aches) 11/2021
1	Lung Injury 10/2021
1	Xerostomia 05/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Anemia 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2020
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 03/2020
1	Microsatellite Instability 01/2020
1	Lactic Acidosis 01/2020
1	Thrombosis (Thrombus) 01/2019
1	Lymphadenopathy 01/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 08/2015
1	Pleural Effusion (Pleural Effusions) 01/2011
1	Residual Neoplasm 03/2009
1	Carcinogenesis 02/2008
1	AIDS-Related Complex (ARC) 09/2007
1	Choledochal Cyst (Choledochal Cysts) 01/2007
1	Brain Neoplasms (Brain Tumor) 01/2005

Drug/Important Bio-Agent (IBA)

5	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 03/2009
4	Ifosfamide FDA LinkGeneric 01/2023 - 03/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2021
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2021
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2021
2	AnthracyclinesIBA 10/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2023
1	VaccinesIBA 05/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2021
1	Dacarbazine (DIC)FDA LinkGeneric 10/2021
1	Denosumab FDA Link 10/2021
1	SynaptophysinIBA 12/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	CytokinesIBA 01/2020
1	LigandsIBA 01/2020
1	DesminIBA 10/2018
1	MyogeninIBA 10/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Anaplastic Lymphoma KinaseIBA 10/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 04/2016
1	Strontium-90IBA 10/2015
1	Diphosphonates (Bisphosphonates)IBA 10/2015
1	LubricantsIBA 08/2015
1	Cisplatin (Platino)FDA LinkGeneric 03/2009

Therapy/Procedure

28	Radiotherapy 02/2024 - 09/2003
21	Drug Therapy (Chemotherapy) 02/2024 - 01/2004
8	Therapeutics 01/2023 - 09/2007
6	Brachytherapy 01/2018 - 02/2007
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2008 - 09/2007
1	Combined Modality Therapy 02/2024
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Conformal Radiotherapy 03/2020
1	Nephrectomy 01/2019
1	Re-Irradiation 01/2017
1	Conservative Treatment 10/2015
1	Drug Tapering 10/2014
1	Induction Chemotherapy 01/2011
1	Mandibular Osteotomy 03/2009